Search by Drug Name or NDC

NDC 68462-0137-05 Oxcarbazepine 150 mg/1 Details

Oxcarbazepine 150 mg/1

Oxcarbazepine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is OXCARBAZEPINE.

MedlinePlus Drug Summary

Oxcarbazepine (Trileptal) is used alone or in combination with other medications to control certain types of seizures in adults and children. Oxcarbazepine extended-release tablets (Oxtellar XR) are used in combination with other medications to control certain types of seizures in adults and children 6 years of age and older. Oxcarbazepine is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.

Related Packages: 68462-0137-05
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Oxcarbazepine

Product Information

NDC	68462-0137
Product ID	68462-137_a47a76fe-644a-48a7-b41b-062961a7d7ef
Associated GPIs	72600046000310
GCN Sequence Number	044336
GCN Sequence Number Description	oxcarbazepine TABLET 150 MG ORAL
HIC3	H4B
HIC3 Description	ANTICONVULSANTS
GCN	21724
HICL Sequence Number	011735
HICL Sequence Number Description	OXCARBAZEPINE
Brand/Generic	Generic
Proprietary Name	Oxcarbazepine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Oxcarbazepine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	150
Active Ingredient Units	mg/1
Substance Name	OXCARBAZEPINE
Labeler Name	Glenmark Pharmaceuticals Inc., USA
Pharmaceutical Class	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA077802
Listing Certified Through	2025-12-31

Package

NDC 68462-0137-05 (68462013705)

Pricing Information	N/A
NDC Package Code	68462-137-05
Billing NDC	68462013705
Package	500 TABLET, FILM COATED in 1 BOTTLE (68462-137-05)
Marketing Start Date	2007-10-09
NDC Exclude Flag	N